Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReal Est.cred Regulatory News (RECI)

Share Price Information for Real Est.cred (RECI)

Share Price is delayed by 15 minutes
Get Live Data
115.50    0.00 (0.00%)
Bid:
116.00
Ask:
117.50
Spread: 1.50 (1.293%)
Market Cap: £255.31m
RECI Live PriceLast checked at - London Stock Exchange

Intraday Real Est.cred Share Chart

Update re Financing Facility

28 Nov 2008 07:00

RNS Number : 1381J
Queen's Walk Investment Limited
28 November 2008
 



Update on QWIL's Financing Facility

As at 27 November 2008, the Company had drawn €40.5 million against its financing facility and had undrawn availability of €94.5 million. Given current market yields, the Company should be able to achieve its return objectives on new investments without the need for additional leverage. In addition, in today's highly volatile markets, the Company could have been exposed to material change clauses that might have triggered the requirement for the repayment of the facility on unfavourable terms.

In light of these circumstances, the Company has successfully negotiated amended terms on a reduced facility, involving a flexible two year repayment schedule of the outstanding debt and has reduced the risk associated with material change clauses that could have forced a repayment of the debt on unfavourable terms. The Company's cash balance of €16.5 million as at 27 November 2008 and continued cash flows from its investment portfolio support the repayment schedule and the timely redemption of the loan facility. The Company believes that the renegotiated loan facility is more prudent than continued dependence on an unpredictable lending market.

The Company has completed negotiations with its lender and the key elements of the amended facility are summarised below.

The Company has committed to repay the outstanding balance of the facility by October 2011, pursuant to an agreed loan amortisation schedule and will not make any further draw downs. The Company believes it should be able to satisfy the loan amortisation schedule with the €16.5 million of cash currently on the balance sheet and the expected cash flows from its investment portfolio. In addition, at the end of each quarter, the Company has pledged to keep the outstanding balance of the financing facility below the product of the then applicable advance rate ("Applicable Percentage") and the value of the investment portfolio plus cash (the "Borrowing Base"). At present, the Company's Borrowing Base is approximately €62.9 million versus a loan balance of €40.5 million

At the end of each calendar quarter, the Company has agreed a target loan amount ("Target Loan Amount") with the lenders. The Company has also agreed to an Applicable Percentage for every quarter. The Target Loan Amount and Applicable Percentage Schedule are detailed below:

Date

Target Loan Amount

Applicable Percentage for Residuals

31 December 2008

35,000,000

30%

31 March 2009 

33,000,000

30%

30 June 2009 

31,000,000

30%

30 September 2009

28,500,000

30%

31 December 2009

27,000,000

27.5%

31 March 2010 

25,000,000

20%

30 June 2010

12,000,000

20%

30 September 2010

10,000,000

20%

31 December 2010

0

20%

31 March 2011

0

10%

The Applicable Percentage for the Company's investment grade bond portfolio will be 50%, 40%, 30% and 15% for AA and above, A and above, BBB and above and BB and above; rated bonds respectively.

The Target Loan Amount will reduce by €11 million in the event that the Magellan 1 transaction is re-financed by the originator, BCP Millennium, before June 2010. The Applicable Percentage for residuals will reduce to 25% if the Magellan 1 transaction is re-financed by BCP Millennium before 31 December 2009.

The Company has committed to use a percentage of its Free Cash (cash proceeds in a quarter less dividends and operating expenses) to amortise the facility. Prior to the Magellan 1 transaction being refinanced, 75% of the Company's Free Cash will be used to repay the facility. After the Magellan 1 transaction is called, 66% of the Free Cash will be used to repay the debt. Once the outstanding balance of the facility is below €22 million, 50% of the Free Cash will be used to repay the facility. If the outstanding balance of the loan facility is less than the Target Loan Amount on the relevant date, the dividend will be capped at €2.25 million per quarter (or approximately a 19% dividend yield on the share price as at 26 November 2008). If the Company is unable to satisfy the loan amortisation schedule, the dividend will be capped at 8% on the share price prevailing at the end of each quarter. A failure to meet the loan amortisation schedule would not trigger an event of default.

In the event that the balance of the facility is greater than the Borrowing Base, the Company will have 20 business days to remedy the breach. Failure to remedy the breach would constitute an event of default. 

The Company has agreed to more asset specific tests in exchange for limiting the scope of the material change triggers and believes that the investment portfolio can support the amended facility.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCZGMZMFNMGRZZ
Date   Source Headline
29th Nov 20197:00 amRNSHalf-year Report
18th Nov 20192:15 pmRNSPress Release - Full Repayment of Atlas Loan
7th Nov 20197:00 amRNSFact Sheet Announcement
7th Nov 20197:00 amRNSFact Sheet Announcement
31st Oct 20193:00 pmRNSTotal Voting Rights
9th Oct 20197:00 amRNSFact Sheet Announcement
1st Oct 201910:00 amRNSClose of Issue of New Ordinary Shares
19th Sep 201910:00 amRNSChange of Senior Independent Director
19th Sep 20197:00 amRNSProposed Placing of New Ordinary Shares
17th Sep 20194:34 pmRNSResult of AGM
11th Sep 20199:30 amRNSInvestor Day
9th Sep 20197:00 amRNSFact Sheet Announcement
28th Aug 20197:30 amEQSHardman & Co Research: Real Estate Credit Investments (RECI): 7%+ yield from well-secured property debt portfolio
8th Aug 20197:00 amRNSNotice of AGM
8th Aug 20197:00 amRNSDividend Declaration
8th Aug 20197:00 amRNSFact Sheet Announcement
9th Jul 201910:30 amRNSDirector/PDMR Shareholding
8th Jul 20194:18 pmRNSDirector/PDMR Shareholding
5th Jul 20197:00 amRNSFact Sheet Announcement
2nd Jul 20192:33 pmRNSNotification of Major Interest in Shares
25th Jun 20194:14 pmRNSPublication of Supplementary Prospectus
25th Jun 20191:00 pmRNSNotification of Major Interest in Shares
25th Jun 20197:00 amRNSDividend Declaration
25th Jun 20197:00 amRNSAnnual Financial Report
11th Jun 20197:00 amRNSFact Sheet Announcement
4th Jun 20192:30 pmRNSNotification of Major Interest in Shares
31st May 201912:15 pmRNSTotal Voting Rights
29th May 20195:15 pmRNSNotification of Major Interest in Shares
29th May 20195:00 pmRNSDirector/PDMR Shareholding
24th May 201912:02 pmRNSClose of Issue of New Ordinary Shares
8th May 20197:01 amRNSProposed Placing of New Ordinary Shares
8th May 20197:00 amRNSFact Sheet Announcement
5th Apr 20197:00 amRNSFact Sheet Announcement
8th Mar 20197:00 amRNSFact Sheet Announcement
27th Feb 201910:04 amRNSChange of Service Providers Announcement
25th Feb 201912:40 pmRNSDividend Announcement replacement
22nd Feb 20193:17 pmRNSDividend Annoucement
7th Feb 20197:00 amRNSFact Sheet Announcement
7th Jan 20194:01 pmRNSNotification of Major Interest in Shares
7th Jan 20197:00 amRNSFactsheet Announcement
17th Dec 20189:49 amRNSNotification of Major Interest in Shares
10th Dec 20187:00 amRNSFactsheet Announcement
30th Nov 20187:03 amRNSDividend Declaration
30th Nov 20187:00 amRNSHalf-year Report
29th Nov 20182:23 pmRNSResult of EGM
6th Nov 20187:00 amRNSInv Mngr Fact Sheet and Q2 Investor Presentation
2nd Nov 20183:49 pmRNSPlacing Programme & Notice of EGM
8th Oct 20187:00 amRNSFactsheet Announcement
21st Sep 20183:13 pmRNSClose of Issue of New Ordinary Shares
20th Sep 201810:55 amRNSProposed Issue of New Ordinary Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.